Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The value of the global schizophrenia drugs market was USD 8.18 Billion in 2024, driven by the prevalence of schizophrenia across the globe. The market is expected to grow at a CAGR of 3.90% during the forecast period of 2025-2034 to reach value of USD 11.99 Billion by 2034.

2024

Base Year

2018-2024

Historical Period

2025-2034

Forecast Period

Compound Annual Growth Rate

3.9%

Value in USD Billion

2025-2034


Schizophrenia Drugs Market Outlook

*this image is indicative*

Global Schizophrenia Drugs Market Trends

Increasing Utilisation of Single-Cell Screening to Offer Lucrative Opportunities to the Market

Healthcare companies are innovating medication manufacturing by utilising high-content single-cell screenings. The development of new potential drugs would be done on a live cellular function model, which will help manufacturers to develop drugs in less time and at effective pricing.

Major Issues with Non-Adherence of Oral Drugs Can Challenge the Market Growth

Majority of the currently available oral drugs for schizophrenia have limited efficacy and can result in negative symptoms with a possibility of relapse in case of non-adherence. Some case may even show severe consequences.

Market Segmentation

The EMR’s report titled “Schizophrenia Drugs Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Therapeutic Class

  • Second-generation Antipsychotics
  • Third-generation Antipsychotics
  • Others

Market Breakup by Route of Administration

  • Oral
  • Injectables

Market Breakup by Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Treatments in the Global Schizophrenia Drugs Market 

Based on treatment, the market for schizophrenia drugs can be bifurcated into oral and injectables. With the development of new key products for the treatment of schizophrenia as a result of the growing number of people suffering from the disease, the injectable segment is expected to hold a major share of the market.

Additionally, several key players in the market have started making substantial investments in research and development for novel treatment solutions.

Injectable-based schizophrenia medications, particularly long-acting injectables, are increasingly gaining popularity owing to their benefits and fewer adverse effects. They also help in suppressing the drawbacks associated with oral treatments. This development in schizophrenia drugs can help the market to grow further with improved patient outcomes and fewer relapses.

Distribution Channels for Schizophrenia Drugs

Based on distribution channels, the market bifurcations include hospital pharmacies, retail pharmacies, and online, among others.

The hospital pharmacy segment is expected to dominate the market, owing to the existence of trained psychiatrists who continue to operate in large hospitals and an increasing number of people with schizophrenia, as well as the increase of long-acting injectables, which physicians may utilise in their normal practice.

Following the hospital pharmacy, the online segment is expected to register the highest CAGR owing to the rapid expansion of internet services and smart devices around the world. People are also shifting towards online services due to the convenience of filling up prescriptions from home.

Competitive Landscape

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global schizophrenia drugs market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments and expansion plans.

Eli Lilly and Company

Eli Lilly and Company is a pharmaceutical company based in the United States, with their headquarters in Indiana. They distribute their products in approximately 125 countries. The company has been in service since 1876. The company works on multiple diseases including Alzheimer’s, Cancer, Diabetes, Immunology, Obesity, and Pain.

AbbVie Inc.

AbbVie Inc. is an American pharmaceutical research and development company, which was founded in 2013. They provide therapeutic services for various areas of disease such as neuroscience, virology, oncology, immunology, and eye care. The company is increasingly invested to develop and deliver new medications.

Alkermes PLC

Alkermes PLC is one of the key global biopharmaceutical companies, which was founded in 1987 and is headquartered in Ireland. The company is engaged in the development of innovative medicines in the medical field of neuroscience and oncology.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other Key players include Otsuka Pharmaceutical Co., Ltd., and Johnson & Johnson Services, Inc., among others.

Schizophrenia Drugs Market Report Snapshots

Schizophrenia Drugs Market Size

Schizophrenia Drugs Market Analysis

Schizophrenia Drugs Trends

Schizophrenia Drugs Treatment Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is expected to grow at a CAGR of 3.90% during the period 2025-2034.

The market is driven by the increasing number of cases of schizophrenia and the wide adoption of long-acting injectables due to their benefits of reduced relapse of the patient.

The rising investment and industrial collaborations in the development of novel treatments for schizophrenia are key trends followed in the market.

The regional markets for the global schizophrenia drugs market include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

The different therapeutic classes in the market include second-generation antipsychotics and third-generation antipsychotics, among others.

The different types of treatment in the market include oral and injectables.

The distribution channels used for schizophrenia drugs include hospital pharmacies, retail pharmacies, and online, among others.

The key players in the market include Eli Lilly and Company, AbbVie Inc., Alkermes PLC, Otsuka Pharmaceutical Co., Ltd., and Johnson & Johnson Services, Inc., among others.

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2024
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Therapeutic Class
  • Route of Administration
  • Distribution Channels
  • Region
Breakup by Therapeutic Class
  • Second-generation Antipsychotics
  • Third-generation Antipsychotics
  • Others
Breakup by Route of Administration
  • Oral
  • Injectables
Breakup by Distribution Channels
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Eli Lilly and Company
  • AbbVie Inc.
  • Alkermes PLC
  • Otsuka Pharmaceutical Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • AstraZeneca
  • Bristol Myers Squibb
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Vanda Pharmaceuticals Inc.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us